search
Back to results

Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels

Primary Purpose

Supraspinatus Calcifying Tendonitis

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK
Extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK
Sponsored by
University of Roma La Sapienza
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Supraspinatus Calcifying Tendonitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • no visible clinical benefits by previous conservative treatment
  • medium and large calcific deposits, according to Bosworth classification
  • type I and II Gartner deposits

Exclusion Criteria:

  • presence of tiny calcific deposits, according to Bosworth classification
  • type III, according to the Gartner classification
  • age (if less than 18 years old), diabetes, coagulation diseases or anticoagulant therapy, tumors, bone infections, previous shoulder surgery, pregnancy, pace-maker, acute bursitis demonstrated by ultrasound imaging, rheumatoid arthritis or other connective tissue diseases

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    1

    2

    Arm Description

    the first group of patients received an energy level of 0.20mJ/mm2, 2400 pulses once a week for 4 weeks.

    The second grouop of patients received 0.10mJ/mm2, 2400 pulses once a week for 4 weeks.

    Outcomes

    Primary Outcome Measures

    Constant Murley Scale
    Constant-Murley scale is the scoring system used to assess shoulder function in four of the studies being reviewed. It combines physical examination tests with subjective evaluations by the patients and consists of 35 points and 65 points respectively. Its strength is the method of its application, which is quite clearly described, and its being an improvement on pre-existing scales

    Secondary Outcome Measures

    Visual Analogic Scale
    It is a horizontal line, 10 cm in length with 0 cm labeled "no pain" and 10 cm labeled "worst pain I have ever had". The patient marks on the line the point that they feel represents their perception of their current state

    Full Information

    First Posted
    May 14, 2012
    Last Updated
    May 18, 2012
    Sponsor
    University of Roma La Sapienza
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01602653
    Brief Title
    Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels
    Official Title
    Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2012
    Overall Recruitment Status
    Completed
    Study Start Date
    November 2008 (undefined)
    Primary Completion Date
    June 2010 (Actual)
    Study Completion Date
    June 2010 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Roma La Sapienza

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to compare two different ranges of energy flux density with Extracorporeal Shock Wave Therapy in treatment of supraspinatus calcifying tendonitis.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Supraspinatus Calcifying Tendonitis

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Investigator
    Allocation
    Randomized
    Enrollment
    46 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    1
    Arm Type
    Active Comparator
    Arm Description
    the first group of patients received an energy level of 0.20mJ/mm2, 2400 pulses once a week for 4 weeks.
    Arm Title
    2
    Arm Type
    Active Comparator
    Arm Description
    The second grouop of patients received 0.10mJ/mm2, 2400 pulses once a week for 4 weeks.
    Intervention Type
    Device
    Intervention Name(s)
    Extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK
    Intervention Description
    an energy level of 0.20mJ/mm2, 2400 pulses once a week for 4 weeks.
    Intervention Type
    Device
    Intervention Name(s)
    Extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK
    Intervention Description
    an energy level of 0.10mJ/mm2, 2400 pulses once a week for 4 weeks.
    Primary Outcome Measure Information:
    Title
    Constant Murley Scale
    Description
    Constant-Murley scale is the scoring system used to assess shoulder function in four of the studies being reviewed. It combines physical examination tests with subjective evaluations by the patients and consists of 35 points and 65 points respectively. Its strength is the method of its application, which is quite clearly described, and its being an improvement on pre-existing scales
    Time Frame
    Change in the mean Constant Murley Scale (CMS) scores at 3 and 6 months was the primary endpoint.
    Secondary Outcome Measure Information:
    Title
    Visual Analogic Scale
    Description
    It is a horizontal line, 10 cm in length with 0 cm labeled "no pain" and 10 cm labeled "worst pain I have ever had". The patient marks on the line the point that they feel represents their perception of their current state
    Time Frame
    The change in the mean Visual Analogic Scale scores from baseline to 3 and 6 months after the intervention

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: no visible clinical benefits by previous conservative treatment medium and large calcific deposits, according to Bosworth classification type I and II Gartner deposits Exclusion Criteria: presence of tiny calcific deposits, according to Bosworth classification type III, according to the Gartner classification age (if less than 18 years old), diabetes, coagulation diseases or anticoagulant therapy, tumors, bone infections, previous shoulder surgery, pregnancy, pace-maker, acute bursitis demonstrated by ultrasound imaging, rheumatoid arthritis or other connective tissue diseases

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    22745199
    Citation
    Ioppolo F, Tattoli M, Di Sante L, Attanasi C, Venditto T, Servidio M, Cacchio A, Santilli V. Extracorporeal shock-wave therapy for supraspinatus calcifying tendinitis: a randomized clinical trial comparing two different energy levels. Phys Ther. 2012 Nov;92(11):1376-85. doi: 10.2522/ptj.20110252. Epub 2012 Jun 28.
    Results Reference
    derived

    Learn more about this trial

    Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels

    We'll reach out to this number within 24 hrs